StockData
Ironwood Pharmaceuticals Inc logo

Ironwood Pharmaceuticals Inc (IRWD) stock

IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)

Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –

Ironwood Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Ironwood Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was 33.4%. For fiscal 2025 it was 8.1%, against 0.3% the year before. The highest annual figure on record is 127.7% in fiscal 2021.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 20258.1%+7.9
FY2024Dec 31, 20240.3%+226.6
FY2023Dec 31, 2023-226.4%−269.0
FY2022Dec 31, 202242.6%−85.1
FY2021Dec 31, 2021127.7%+100.5
FY2020Dec 31, 202027.3%+22.2
FY2019Dec 31, 20195.0%+86.5
FY2018Dec 31, 2018-81.5%−42.3
FY2017Dec 31, 2017-39.2%−9.4
FY2016Dec 31, 2016-29.8%+65.6
FY2015Dec 31, 2015-95.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202645.4%+17.7
Q1 FY2026Mar 31, 202638.3%+129.2
Q4 FY2025Dec 31, 2025-4.8%−7.3
Q3 FY2025Sep 30, 202532.8%+28.9
Q2 FY2025Jun 30, 202527.7%+28.6
Q1 FY2025Mar 31, 2025-90.9%−85.3
Q4 FY2024Dec 31, 20242.5%+3.4
Q3 FY2024Sep 30, 20244.0%−9.5
Q2 FY2024Jun 30, 2024-0.9%+988.3
Q1 FY2024Mar 31, 2024-5.6%−49.5
Q4 FY2023Dec 31, 2023-0.9%−46.5
Q3 FY2023Sep 30, 202313.5%−32.8
Q2 FY2023Jun 30, 2023-989.2%−1027.3
Q1 FY2023Mar 31, 202343.9%+4.1
Q4 FY2022Dec 31, 202245.6%+10.3
Q3 FY2022Sep 30, 202246.3%−7.5
Q2 FY2022Jun 30, 202238.1%−338.0
Q1 FY2022Mar 31, 202239.8%−5.2
Q4 FY2021Dec 31, 202135.3%−1.7
Q3 FY2021Sep 30, 202153.8%+20.6
Q2 FY2021Jun 30, 2021376.1%+348.0
Q1 FY2021Mar 31, 202144.9%+40.8
Q4 FY2020Dec 31, 202037.0%−0.9
Q3 FY2020Sep 30, 202033.3%+17.5
Q2 FY2020Jun 30, 202028.2%+16.2
Q1 FY2020Mar 31, 20204.2%+90.4
Q4 FY2019Dec 31, 201937.9%+49.7
Q3 FY2019Sep 30, 201915.7%+281.2
Q2 FY2019Jun 30, 201912.0%+72.9
Q1 FY2019Mar 31, 2019-86.3%−23.9
Q4 FY2018Dec 31, 2018-11.9%−24.7
Q3 FY2018Sep 30, 2018-265.4%−228.2
Q2 FY2018Jun 30, 2018-60.9%+7.1
Q1 FY2018Mar 31, 2018-62.4%+38.3
Q4 FY2017Dec 31, 201712.8%+28.3
Q3 FY2017Sep 30, 2017-37.2%+13.0
Q2 FY2017Jun 30, 2017-68.0%–
Q1 FY2017Mar 31, 2017-100.6%–
Q4 FY2016Dec 31, 2016-15.4%–
Q3 FY2016Sep 30, 2016-50.2%–

More Ironwood Pharmaceuticals figures

See a number that looks wrong?